IL90339A0 - Anti-cytotoxic protein and its purification - Google Patents

Anti-cytotoxic protein and its purification

Info

Publication number
IL90339A0
IL90339A0 IL90339A IL9033989A IL90339A0 IL 90339 A0 IL90339 A0 IL 90339A0 IL 90339 A IL90339 A IL 90339A IL 9033989 A IL9033989 A IL 9033989A IL 90339 A0 IL90339 A0 IL 90339A0
Authority
IL
Israel
Prior art keywords
purification
cytotoxic protein
cytotoxic
protein
Prior art date
Application number
IL90339A
Other versions
IL90339A (en
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL9033989A priority Critical patent/IL90339A/en
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL90339A0 publication Critical patent/IL90339A0/en
Priority to AT90109337T priority patent/ATE119942T1/en
Priority to EP90109337A priority patent/EP0398327B2/en
Priority to CA002458875A priority patent/CA2458875A1/en
Priority to DE69017753T priority patent/DE69017753T3/en
Priority to AU55141/90A priority patent/AU636608B2/en
Priority to ES90109337T priority patent/ES2072330T5/en
Priority to DK90109337.7T priority patent/DK0398327T4/en
Priority to CA002017025A priority patent/CA2017025C/en
Priority to JP2128956A priority patent/JP2866706B2/en
Priority to ZA903843A priority patent/ZA903843B/en
Priority to US07/879,373 priority patent/US5512544A/en
Priority to US08/476,862 priority patent/US6262239B1/en
Priority to US08/477,347 priority patent/US6232446B1/en
Publication of IL90339A publication Critical patent/IL90339A/en
Priority to IL11993296A priority patent/IL119932A0/en
Priority to US09/800,908 priority patent/US6602993B2/en
Priority to US09/800,909 priority patent/US6555111B2/en
Priority to US10/319,536 priority patent/US8138323B2/en
Priority to US10/423,927 priority patent/US20030228312A1/en
Priority to US10/632,929 priority patent/US7455977B2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL9033989A 1987-09-13 1989-05-18 Anti-cytotoxic protein and its purification IL90339A (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IL9033989A IL90339A (en) 1989-05-18 1989-05-18 Anti-cytotoxic protein and its purification
AT90109337T ATE119942T1 (en) 1989-05-18 1990-05-17 TUMOR NECROSE FACTOR BINDING PROTEIN II, ITS PURIFICATION AND SPECIFIC ANTIBODIES.
EP90109337A EP0398327B2 (en) 1989-05-18 1990-05-17 Tumor necrosis factor binding protein II, its purification and antibodies thereto
CA002458875A CA2458875A1 (en) 1989-05-18 1990-05-17 Tumor necrosis factor (tnf) binding protein ii, its purification and antibodies thereto
DE69017753T DE69017753T3 (en) 1989-05-18 1990-05-17 Tumor necrosis factor binding protein II, its purification and specific antibodies
AU55141/90A AU636608B2 (en) 1989-05-18 1990-05-17 Tumor necrosis factor binding protein II, it's purification and antibodies thereto
ES90109337T ES2072330T5 (en) 1989-05-18 1990-05-17 Binding Protein II to the Tumor Necrosis Factor, its purification and antibodies against them
DK90109337.7T DK0398327T4 (en) 1989-05-18 1990-05-17 Tumor necrosis factor binding protein, its purification and antibodies thereto
CA002017025A CA2017025C (en) 1989-05-18 1990-05-17 Tumor necrosis factor binding protein ii, its purification and antibodies thereto
JP2128956A JP2866706B2 (en) 1989-05-18 1990-05-18 Tumor necrosis factor binding protein
ZA903843A ZA903843B (en) 1989-05-18 1990-05-18 Tumor necrosis factor binding protein ii,its purification and antibodies thereto
US07/879,373 US5512544A (en) 1987-09-13 1992-05-07 Pharmaceutical compositions comprising an anticytokine
US08/476,862 US6262239B1 (en) 1989-05-18 1995-06-07 TNF receptor-specific antibodies
US08/477,347 US6232446B1 (en) 1989-05-18 1995-06-07 TNF ligands
IL11993296A IL119932A0 (en) 1989-05-18 1996-12-30 Antibodies to anti-cytotoxic protein
US09/800,908 US6602993B2 (en) 1989-05-18 2001-03-08 DNA molecule encoding TNF binding ligands and vectors and host cells containing the DNA molecule
US09/800,909 US6555111B2 (en) 1989-05-18 2001-03-08 Method of inhibiting the cytocidal effect of TNF with TNF receptor-specific antibodies
US10/319,536 US8138323B2 (en) 1989-05-18 2002-12-16 Isolated cDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA
US10/423,927 US20030228312A1 (en) 1989-05-18 2003-04-28 TNF receptor-specific antibodies
US10/632,929 US7455977B2 (en) 1989-05-18 2003-08-04 Methods of determining the level of human TBP-II with anti-TBP-II antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9033989A IL90339A (en) 1989-05-18 1989-05-18 Anti-cytotoxic protein and its purification

Publications (2)

Publication Number Publication Date
IL90339A0 true IL90339A0 (en) 1989-12-15
IL90339A IL90339A (en) 1996-10-16

Family

ID=11059973

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9033989A IL90339A (en) 1987-09-13 1989-05-18 Anti-cytotoxic protein and its purification

Country Status (2)

Country Link
IL (1) IL90339A (en)
ZA (1) ZA903843B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
JP2001513754A (en) 1996-12-06 2001-09-04 アムジェン インコーポレイテッド Combination therapy using TNF binding proteins for treating TNF-mediated diseases

Also Published As

Publication number Publication date
ZA903843B (en) 1991-05-29
IL90339A (en) 1996-10-16

Similar Documents

Publication Publication Date Title
IL106278A0 (en) Bone formation-inducing protein
EP0445801A3 (en) Peptide and its use
GB9314802D0 (en) Modified proteins
ZA895460B (en) Novel proteins
GB9003621D0 (en) Protein factor
EP0416363A3 (en) Modified polyarylenesulfides
ZA895461B (en) Modified proteins
GB9027728D0 (en) Novel protein
IL90339A0 (en) Anti-cytotoxic protein and its purification
EP0540575A4 (en) Human meg-csf protein and methods
GB8816095D0 (en) Protein
ZA907279B (en) Antibodies and proteins
GB9221587D0 (en) Modified proteins
GB9127319D0 (en) Modified proteins
GB8921172D0 (en) Proteins
GB9226346D0 (en) Proteins
GB9227189D0 (en) Proteins
ZA938677B (en) Proteins
GB9208397D0 (en) Proteins
GB9207488D0 (en) Proteins
GB9120219D0 (en) Protein purification
IE880272L (en) Protein extracts
IE901160L (en) Pp4-delta proteins
GB9017728D0 (en) Proteins
GB9116000D0 (en) Proteins

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed